Log in

NASDAQ:AXGTAxovant Gene Therapies Earnings Date, Estimates & History

+0.01 (+0.30 %)
(As of 05/25/2020 04:00 PM ET)
Today's Range
Now: $3.38
50-Day Range
MA: $3.19
52-Week Range
Now: $3.38
Volume83,557 shs
Average Volume210,605 shs
Market Capitalization$124.46 million
P/E RatioN/A
Dividend YieldN/A


Axovant Gene Therapies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, June 9th, 2020 based off prior year's report dates.

Axovant Gene Therapies Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Axovant Gene Therapies (NASDAQ:AXGT) Earnings Estimates

2020 EPS Consensus Estimate: ($2.90)
2021 EPS Consensus Estimate: ($2.43)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.70)($0.70)($0.70)
Q2 20201($0.84)($0.84)($0.84)
Q3 20202($0.83)($0.71)($0.77)
Q4 20203($0.68)($0.52)($0.59)
Q1 20212($0.72)($0.50)($0.61)
Q2 20212($0.68)($0.50)($0.59)
Q3 20212($0.73)($0.50)($0.62)
Q4 20212($0.79)($0.44)($0.62)

Axovant Gene Therapies (NASDAQ AXGT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/10/2020Q3 2020($0.78)($0.6160)($0.62)N/A
11/8/2019Q2 2020($1.15)($0.61)($0.61)N/A
8/9/2019Q1 2020($1.34)($1.23)($1.23)N/A
2/7/2019Q3 2019($2.16)($2.16)($0.27)N/A
11/7/2018Q2 2019($3.04)($2.24)($0.28)N/A
8/7/2018Q1 2019($1.28)($3.84)($0.48)N/A
6/11/2018Q4 2018($2.80)($1.84)($0.23)N/A
2/9/2018Q3 2018($4.32)($0.54)N/A
11/2/2017Q2 2018($4.40)($5.12)($0.64)N/A
8/7/2017Q1 2018($4.16)($5.20)($0.65)N/A
6/13/2017Q4 2017($4.08)($4.24)($0.53)N/A
2/14/2017Q3 2017($3.60)($3.84)($0.48)N/A
11/7/2016Q2 2017($3.20)($3.44)($0.43)N/A
8/15/2016Q1 2017($2.96)($3.04)($0.38)N/A
6/6/2016Q4 2016($1.92)($2.40)($0.30)N/A
2/9/2016Q3 2016($1.20)($5.12)($0.64)N/A
11/2/2015Q2 2016($1.20)($0.96)($0.12)N/A
8/11/2015Q1 2016($0.80)($2.80)($0.35)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.